Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Clinitech Laboratory Ltd.
 
BSE Code 544220
ISIN Demat INE0QMR01015
Book Value (Rs.) 38.69
NSE Code NA
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 86.73
TTM PE (x) 21.97
TTM EPS (Rs.) 1.73
Face Value (Rs.) 10  
Source DateBoard Meeting DateDetails
19-Nov-2025 22-Nov-2025 Inter alia, to consider and approve formation of Subsidiary in the name & style as ?Medicarenx Multispeciality Hospital Private Limited? and subscribe the memorandum
07-Nov-2025 12-Nov-2025 Half Yearly Results
13-Aug-2025 19-Aug-2025 Inter alia, to consider and approve:- To consider and approve appointment of director retiring by rotation; To approve the Board s report of the company along with all annexures thereof for the FY 2024-25; To authorize the Board of Directors to file Annual return; To consider and approve notice convening 15th Annual General Meeting and the date, time & venue thereof; To finalize the appointment of Mr. Deep Shukla, Practising Company Secretary as the scrutinizer to oversee the voting process in a fair and transparent manner; To authorise and designate Mr. Jagdish Nayak, Managing Director of the company for providing information w.r.t beneficial interest in shares of the company Any other matter with the permission of the Chair.
03-Jun-2025 06-Jun-2025 Inter-alia to consider the following: 1. To take a note of Resignation of Mr. Bharat Kumar Bohra from the post of Company Secretary & Compliance Officer; 2. To consider and approve appointment of Company Secretary & Compliance Officer; 3. Any other matter with the permission of the Chair.
19-May-2025 23-May-2025 Audited Results
19-Mar-2025 25-Mar-2025 Inter alia, to consider and approve:- 1. To consider and approve the appointment of M/s. Kalpesh Khatri & Associates, Chartered Accountants (Firm Regn No: 0139570W) as an Internal Auditors of the Company; 2. To consider and approve appointment of M/s. Deep Shukla & Associates as a Secretarial Auditor of the Company of the Company; 3. Any other matter with the permission of the Chair.
06-Nov-2024 13-Nov-2024 Half Yearly Results
close X

Download Client Registration Documents

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of GTC Orders | Saral Account opening form | Rights and Obligation for DP
QR Code for DP | QR Code for Stock Broker | ARISTRO MGT7 | CSR Policy Aristro
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.